Deutsch et al. showed that NR4A3 could inhibit aggressive lymphoma by upregulating pro-apoptotic genes,28 while Yang et al. found that NR4A3 downregulation enhanced the proliferation and invasiveness of BLCA cells.19 The gene discussed is NR4A3; the disease is bladder transitional cell carcinoma.